Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Psyence Biomedical Ltd (NASDAQ: PBM) closed at $3.0 in the last session, down -5.06% from day before closing price of $3.16. In other words, the price has decreased by -$5.06 from its previous closing price. On the day, 0.37 million shares were traded. PBM stock price reached its highest trading level at $3.145 during the session, while it also had its lowest trading level at $2.82.
Ratios:
We take a closer look at PBM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.64 and its Current Ratio is at 0.64.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBM now has a Market Capitalization of 5616153 and an Enterprise Value of -5921356.
Stock Price History:
The Beta on a monthly basis for PBM is 0.25, which has changed by -0.920202 over the last 52 weeks, in comparison to a change of 0.18286073 over the same period for the S&P500. Over the past 52 weeks, PBM has reached a high of $63.36, while it has fallen to a 52-week low of $2.36. The 50-Day Moving Average of the stock is -11.16%, while the 200-Day Moving Average is calculated to be -45.40%.
Shares Statistics:
According to the various share statistics, PBM traded on average about 1.50M shares per day over the past 3-months and 43630 shares per day over the past 10 days. Insiders hold about 0.00% of the company’s shares, while institutions hold 42.85% stake in the company. Shares short for PBM as of 1760486400 were 130857 with a Short Ratio of 0.09, compared to 1757894400 on 38264. Therefore, it implies a Short% of Shares Outstanding of 130857 and a Short% of Float of 55.86.
